Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000290094 refers to a novel, sense, intronic non-coding RNA transcript located within the DNAJC6 gene. It is not a protein-coding gene nor a known functional RNA (such as microRNA or lncRNA with characterized biological activity). There is currently no evidence that this transcript acts as a therapeutic target, biomarker, or regulatory RNA with specific biological or disease relevance. Some annotated "novel transcript" entries are computational predictions or products of incomplete transcriptome annotation and may not represent functional molecules. This entry does not correspond to a protein, enzyme, receptor, transporter, or other well-characterized drug target. It is neither the canonical DNAJC6 gene nor its principal transcript; rather, it is an uncharacterized transcript within the DNAJC6 locus. There is no evidence of a well-established role in any biological process, molecular function, or disease. It is unlikely to be the intended or valid entity for functional or drug discovery databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, sense intronic to DNAJC6.